menu
    • menu

    Company profile for Fennec Pharmaceuticals

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of PEDMARK TM (a unique formulation of Sodium Thiosulfate) for the prevention of ototoxicity from cisplatin in pediatric patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fennec PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    PO Box 13628 68 TW Alexander Drive Research Triangle Park, NC 27709
    Telephone
    Telephone
    919-636-4530
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://fennecpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/FennecPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BD&L Summit

    BD&L Summit

    Not Confirmed

    envelop Contact Supplier

    BD&L Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fennec Pharma Accepts Abstracts At 2026 ASCO Meeting
    Fennec Pharma Accepts Abstracts At 2026 ASCO Meeting

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7197417

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Fennec Pharma Reveals 2025 Financials And Business Update
    Fennec Pharma Reveals 2025 Financials And Business Update

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261052/0/en/Fennec-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Fennec Pharma Reports Full Year and Q4 2023 Financial Results
    Fennec Pharma Reports Full Year and Q4 2023 Financial Results

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258049/0/en/Fennec-Pharmaceuticals-to-Report-Full-Year-and-Fourth-Quarter-2025-Financial-Results-on-March-24-2026.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement
    Fennec Pharma Resolves PEDMARK Patent Litigation With Settlement

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256242/0/en/Fennec-Pharmaceuticals-Announces-Settlement-Agreement-Resolving-PEDMARK-Patent-Litigation.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    Fennec Pharma Partners With Tampa General Cancer Institute
    Fennec Pharma Partners With Tampa General Cancer Institute

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249229/0/en/Fennec-Pharmaceuticals-Announces-Clinical-Research-Collaboration-with-Tampa-General-Hospital-Cancer-Institute.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Southpoint holdings in Fennec Pharmaceuticals Inc.
    Southpoint holdings in Fennec Pharmaceuticals Inc.

    26 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/26/3210668/0/en/Southpoint-holdings-in-Fennec-Pharmaceuticals-Inc-TSX-FENC.html

    GLOBENEWSWIRE
    26 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search